Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC.
Qayyum A, Hwang KP, Stafford J, Verma A, Maru DM, Sandesh S, Sun J, Pestana RC, Avritscher R, Hassan MM, Amin H, Rashid A, Wistuba II, Ehman RL, Ma J, Kaseb AO. Qayyum A, et al. Among authors: pestana rc. J Immunother Cancer. 2019 Nov 28;7(1):329. doi: 10.1186/s40425-019-0766-y. J Immunother Cancer. 2019. PMID: 31779702 Free PMC article.
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Kaseb AO, Sánchez NS, Sen S, Kelley RK, Tan B, Bocobo AG, Lim KH, Abdel-Wahab R, Uemura M, Pestana RC, Qiao W, Xiao L, Morris J, Amin HM, Hassan MM, Rashid A, Banks KC, Lanman RB, Talasaz A, Mills-Shaw KR, George B, Haque A, Raghav KPS, Wolff RA, Yao JC, Meric-Bernstam F, Ikeda S, Kurzrock R. Kaseb AO, et al. Among authors: pestana rc. Clin Cancer Res. 2019 Oct 15;25(20):6107-6118. doi: 10.1158/1078-0432.CCR-18-3341. Epub 2019 Jul 30. Clin Cancer Res. 2019. PMID: 31363003 Free PMC article.
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.
Mohamed YI, Lee S, Xiao L, Hassan MM, Qayyum A, Hiatia R, Pestana RC, Haque A, George B, Rashid A, Duda DG, Elghazaly H, Wolff RA, Morris JS, Yao J, Amin HM, Kaseb AO. Mohamed YI, et al. Among authors: pestana rc. Oncotarget. 2021 Apr 13;12(8):756-766. doi: 10.18632/oncotarget.27924. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889299 Free PMC article.
Hepatocellular Carcinoma Immunotherapy.
Sperandio RC, Pestana RC, Miyamura BV, Kaseb AO. Sperandio RC, et al. Among authors: pestana rc. Annu Rev Med. 2022 Jan 27;73:267-278. doi: 10.1146/annurev-med-042220-021121. Epub 2021 Oct 4. Annu Rev Med. 2022. PMID: 34606324 Review.
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma.
Yavuz BG, Pestana RC, Abugabal YI, Krishnan S, Chen J, Hassan MM, Wolff RA, Rashid A, Amin HM, Kaseb AO. Yavuz BG, et al. Among authors: pestana rc. Oncotarget. 2020 Mar 31;11(13):1186-1201. doi: 10.18632/oncotarget.27532. eCollection 2020 Mar 31. Oncotarget. 2020. PMID: 32284794 Free PMC article. Review.
26 results